CHARACTERIZATION OF PLATELET-ACTIVATING FACTOR-INDUCED ELEVATION OF CYTOSOLIC FREE-CALCIUM LEVEL IN NEUROHYBRID NCB-20 CELLS

被引:30
作者
YUE, TL [1 ]
GLEASON, MM [1 ]
HALLENBECK, J [1 ]
FEUERSTEIN, G [1 ]
机构
[1] UNIFORMED SERV UNIV HLTH SCI, DEPT NEUROL, BETHESDA, MD 20814 USA
关键词
D O I
10.1016/0306-4522(91)90208-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of platelet-activating factor on the intracellular cytosolic level of free calcium ([Ca2+]i) was studied in neurohybrid NCB-20 cells. In fura-2-loaded NCB-20 cells, platelet-activating factor induced an immediate and concentration-dependent increase in [Ca2+]i with a maximum increase of 334 +/- 27 nM above a basal value of 147 +/- 6 nM (n = 40). Platelet-activating factor-induced [Ca2+]i mobilization was inhibited by the platelet-activating factor antagonists BN 50739, WEB 2086, SRI 63-441 and BN 52021 in a dose-dependent manner with IC50 values of 12, 38, 897 and 45000 nM, respectively. The calcium-channel blockers nifedipine (10-mu-M) and diltiazem (10-mu-M) had no effect on the platelet-activating factor-induced increase in [Ca2+]i; however, extracellular Ca2+-depletion caused a 63.6 +/- 4.7% reduction of platelet-activating factor-induced increase in [Ca2+]i (n = 5, P < 0.001). The remaining 36% contributed from intracellular sources was completely inhibited by 10-mu-M of 8-(N,N-diethylamine)octyl 3,4,5-trimethoxytenzoate hydrochloride (TMB-8). NCB-20 cells exhibited homologous desensitization to sequential addition of platelet-activating factor, but no heterologous desensitization between platelet-activating factor and bradykinin or ATP was observed. These data suggest that activation of the neuronal platelet-activating factor receptor results in an increase in [Ca2+]i primarily via a receptor-operated rather than a voltage-dependent calcium-channel and to a lesser extent from intracellular Ca2+ release. Our findings may contribute to an understanding of the mechanism of platelet-activating factor actions on neuronal cells.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 42 条
[1]  
BARZAGHI G, 1989, J PHARMACOL EXP THER, V248, P559
[2]   PLATELET-ACTIVATING FACTOR, A NEW MEDIATOR OF ANAPHYLAXIS AND IMMUNE-COMPLEX DEPOSITION FROM RABBIT AND HUMAN BASOPHILS [J].
BENVENISTE, J .
NATURE, 1974, 249 (5457) :581-582
[3]   PLATELET-ACTIVATING FACTOR ANTAGONIST BN52021 DECREASES ACCUMULATION OF FREE POLY-UNSATURATED FATTY-ACID IN MOUSE-BRAIN DURING ISCHEMIA AND ELECTROCONVULSIVE SHOCK [J].
BIRKLE, DL ;
KURIAN, P ;
BRAQUET, P ;
BAZAN, NG .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (06) :1900-1905
[4]   THE INTRACELLULAR CALCIUM-ANTAGONIST TMB-8 [8-(NN-DIETHYLAMINO)OCTYL-3,4,5-TRIMETHOXYBENZOATE] INHIBITS MITOCHONDRIAL ATP PRODUCTION IN RAT THYMOCYTES [J].
BRAND, MD ;
FELBER, SM .
BIOCHEMICAL JOURNAL, 1984, 224 (03) :1027-1030
[5]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[6]  
BRAQUET P, 1989, PLATELET ACTIVATING, P85
[7]   STUDIES ON MECHANISM OF ACTION OF A NEW CA2+ ANTAGONIST, 8-(N,N-DIETHYLAMINO)OCTYL 3,4,5-TRIMETHOXYBENZOATE HYDROCHLORIDE IN SMOOTH AND SKELETAL-MUSCLES [J].
CHIOU, CY ;
MALAGODI, MH .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 53 (02) :279-285
[8]   CHARACTERIZATION OF BRADYKININ-INDUCED PHOSPHOINOSITIDE TURNOVER IN NEUROHYBRID NCB-20 CELLS [J].
CHUANG, DM ;
DILLONCARTER, O .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) :505-513
[9]   PRESENCE OF SPECIFIC BINDING-SITES FOR PLATELET-ACTIVATING FACTOR (PAF) IN BRAIN [J].
DOMINGO, MT ;
SPINNEWYN, B ;
CHABRIER, PE ;
BRAQUET, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (02) :730-736
[10]  
FRERICHS KU, 1991, IN PRESS J NEUROSURG